Apple will disable the blood-oxygen feature on premium watches sold in the US as part of a patent dispute

Posted 1/19/24

Apple says it will disable a blood-oxygen monitoring feature on its two most popular watches in the U.S. beginning Thursday to comply with a court-ordered revival of a sales ban stemming from a …

This item is available in full to subscribers.

Please log in to continue

Log in